PENUMBRA INC (PEN) Stock Fundamental Analysis

NYSE:PEN • US70975L1070

340.16 USD
-2.14 (-0.63%)
At close: Mar 3, 2026
340.16 USD
0 (0%)
After Hours: 3/3/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 184 industry peers in the Health Care Equipment & Supplies industry. PEN has an excellent financial health rating, but there are some minor concerns on its profitability. PEN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • PEN had positive earnings in the past year.
  • PEN had a positive operating cash flow in the past year.
  • In multiple years PEN reported negative net income over the last 5 years.
  • In multiple years PEN reported negative operating cash flow during the last 5 years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.40%, PEN belongs to the top of the industry, outperforming 90.76% of the companies in the same industry.
  • The Return On Equity of PEN (12.07%) is better than 89.13% of its industry peers.
  • The Return On Invested Capital of PEN (7.37%) is better than 82.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PEN is significantly below the industry average of 8.75%.
  • The last Return On Invested Capital (7.37%) for PEN is above the 3 year average (2.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROIC 7.37%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

  • PEN's Profit Margin of 12.30% is amongst the best of the industry. PEN outperforms 86.41% of its industry peers.
  • PEN's Profit Margin has declined in the last couple of years.
  • PEN's Operating Margin of 12.95% is amongst the best of the industry. PEN outperforms 80.43% of its industry peers.
  • In the last couple of years the Operating Margin of PEN has declined.
  • With a decent Gross Margin value of 66.80%, PEN is doing good in the industry, outperforming 71.74% of the companies in the same industry.
  • PEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for PEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • PEN has an Altman-Z score of 22.81. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
  • PEN has a Altman-Z score of 22.81. This is amongst the best in the industry. PEN outperforms 96.74% of its industry peers.
  • The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.15, PEN belongs to the best of the industry, outperforming 92.93% of the companies in the same industry.
  • A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.02, PEN is doing good in the industry, outperforming 71.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 22.81
ROIC/WACC0.74
WACC9.98%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 6.73 indicates that PEN has no problem at all paying its short term obligations.
  • PEN has a Current ratio of 6.73. This is amongst the best in the industry. PEN outperforms 85.87% of its industry peers.
  • A Quick Ratio of 4.18 indicates that PEN has no problem at all paying its short term obligations.
  • The Quick ratio of PEN (4.18) is better than 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 6.73
Quick Ratio 4.18
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.80%, which is quite impressive.
  • The Earnings Per Share has been growing by 84.42% on average over the past years. This is a very strong growth
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.81% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.43% on average over the next years. This is quite good.
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue Next Year14.66%
Revenue Next 2Y14.13%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • PEN is valuated quite expensively with a Price/Earnings ratio of 88.58.
  • 65.76% of the companies in the same industry are more expensive than PEN, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of PEN to the average of the S&P500 Index (26.83), we can say PEN is valued expensively.
  • With a Price/Forward Earnings ratio of 66.51, PEN can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than 65.76% of the companies in the same industry.
  • PEN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 88.58
Fwd PE 66.51
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 64.67% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than the industry average as 69.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 87.46
EV/EBITDA 67.49
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of PEN may justify a higher PE ratio.
  • A more expensive valuation may be justified as PEN's earnings are expected to grow with 28.35% in the coming years.
PEG (NY)2.67
PEG (5Y)1.05
EPS Next 2Y30.32%
EPS Next 3Y28.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PENUMBRA INC

NYSE:PEN (3/3/2026, 8:04:00 PM)

After market: 340.16 0 (0%)

340.16

-2.14 (-0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners97.98%
Inst Owner Change1.37%
Ins Owners3.7%
Ins Owner Change3.06%
Market Cap13.35B
Revenue(TTM)N/A
Net Income(TTM)164.03M
Analysts69.57
Price Target365.95 (7.58%)
Short Float %4.92%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)6.81%
PT rev (3m)14.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.01%
EPS NY rev (1m)0.18%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 88.58
Fwd PE 66.51
P/S 10.01
P/FCF 87.46
P/OCF 65.66
P/B 9.82
P/tB 11.26
EV/EBITDA 67.49
EPS(TTM)3.84
EY1.13%
EPS(NY)5.11
Fwd EY1.5%
FCF(TTM)3.89
FCFY1.14%
OCF(TTM)5.18
OCFY1.52%
SpS33.99
BVpS34.63
TBVpS30.21
PEG (NY)2.67
PEG (5Y)1.05
Graham Number54.7
Profitability
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROCE 10.97%
ROIC 7.37%
ROICexc 10.5%
ROICexgc 12.46%
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
FCFM 11.44%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA 0.11
Cap/Depr 291.22%
Cap/Sales 3.8%
Interest Coverage 250
Cash Conversion 106.89%
Profit Quality 93.05%
Current Ratio 6.73
Quick Ratio 4.18
Altman-Z 22.81
F-Score7
WACC9.98%
ROIC/WACC0.74
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.14%
Revenue Next Year14.66%
Revenue Next 2Y14.13%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year83.01%
EBIT Next 3Y41.87%
EBIT Next 5Y27.13%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PEN.


What is the valuation status of PENUMBRA INC (PEN) stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


Can you provide the profitability details for PENUMBRA INC?

PENUMBRA INC (PEN) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for PEN stock?

The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 33.19% in the next year.